Preview Mode Links will not work in preview mode

Eagle's Eye View: Your Weekly CV Update From

Aug 28, 2019

This week's View explores the impact of anticoagulation therapy after bioprosthetic aortic valve replacement on valve hemodynamics and clinical outcomes, the relative clinical benefit of adding alirocumab to statins in acute coronary syndrome patients with prior coronary artery bypass grafting, and whether the achievement of N-terminal pro-B-type natriuretic peptide to ≤1000 pg/ml at 90 days with guideline-directed medical therapy predicts outcomes.